October 2019 PMID 31475794

Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction.

Scott D Solomon, John J V McMurray, Inder S Anand, Junbo Ge, Carolyn S P Lam, Aldo P Maggioni, Felipe Martinez, Milton Packer, Marc A Pfeffer, Burkert Pieske, Margaret M Redfield, Jean L Rouleau, Dirk J van Veldhuisen, Faiez Zannad, Michael R Zile

Download social card

Mentions

283

Peak: 73 in Oct 2019

across 5 sources since Sep 2019

Extended reach

1,636,103

potential audience

Total likes

298

Video views

558

Mentions per month

Sep 2019 – Dec 2024

Where it's discussed

X / Twitter180 posts
News71 articles
Facebook22 posts
Blogs6 articles
YouTube4 videos

AI synopsis

What people are saying

The discussions highlight the clinical nuances of the publication, such as when one poster noted the findings from the PARAGON trial regarding the limited benefits of sacubitril-valsartan for patients with preserved ejection fraction. Terms like 'no significant benefit' and phrases indicating skepticism about the medication’s effectiveness show a cautionary tone among posters. The combination of interest in the topic and varying levels of agreement showcases a vibrant dialogue enriched by both support and critique.

AgreementNeither agree nor disagree

The discussions display mixed reactions to the findings, with some expressing skepticism regarding the efficacy of sacubitril-valsartan in the specified population.

InterestHigh interest

There is a high level of curiosity present as many participants are actively seeking insights and discussing implications of the study.

EngagementModerate engagement

While there is considerable interest, the depth of engagement varies with some participants merely sharing links or opinions without much analysis.

ImpactModerate impact

Perceptions of impact are moderate, as users generally recognize the significance of the findings but also emphasize the limitations and ongoing questions about treatment options.

Abstract in brief

Angiotensin receptor-neprilysin inhibitor sacubitril-valsartan showed a reduced risk of hospitalization for heart failure and cardiovascular death compared to valsartan in patients with heart failure and reduced ejection fraction.
A clinical trial with 4,822 patients assessed various outcomes, including heart failure hospitalizations, cardiovascular deaths, and changes in symptoms or renal function.
Results indicated that the sacubitril-valsartan group had fewer primary events, better improvements in heart failure symptoms, and a lower incidence of worsening renal function compared to the valsartan group.

Read the full abstract

All mentions

Comparative Analysis of Tirzepatide and Semaglutide in Obesity Management

This week, John Mandrola MD discusses Tirzepatide vs semaglutide in obesity treatment, exploring their complexities and implications for heart failure outcomes. He also addresses the misuse of meta-analyses in heart…

Medscape · Dec 6, 2024 524 views

Early Anticoagulation Benefits in Atrial Fibrillation Stroke Patients

This week's podcast discusses the timing of direct oral anticoagulant initiation in atrial fibrillation patients post-acute ischemic stroke. The study reveals that early treatment is linked to a reduced incidence of…

Medscape · Mar 27, 2024 20 views

Impact of Angiotensin Inhibition on Heart Failure Outcomes

In this week's podcast, John Mandrola MD discusses the PROTECTED TAVR trial and highlights the benefits of angiotensin-neprilysin inhibitor sacubitril-valsartan in reducing hospitalization and death in heart failure…

Medscape · Mar 27, 2024 9 views

COVID-19 Impact on Cardiology and Heart Failure Management

In this episode, John Mandrola MD discusses critical topics including heart failure classifications and the implications of COVID-19 on cardiology. The video integrates insights from recent guidelines on atrial…

Medscape · Mar 27, 2024 6 views

Andrea

@Andrea855455091 · X

RT @enry101: Very interesting Editorial comment on the PARAGLIDE-HF trial recently published in JACC and evaluating Angiotensin-Neprilysin…

May 24, 2023 · 1 share · 3 followers View post →

Enrico Bonnì

@enry101 · X

Very interesting Editorial comment on the PARAGLIDE-HF trial recently published in JACC and evaluating Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction. #HeartFailure #HFpEF #ARNI #cardiology #PARAGLIDE @MRMehraMD https://t.co/00xrZFGXmM

May 23, 2023 · 1 like · 1 share · 554 followers View post →

@MARTINSVEL

@MARTINSVEL · X

RT @javier20ch: ✍️Artículos originales:

May 6, 2023 · 12 shares · 413 followers View post →

Faby G.

@Fabiolaghh · X

RT @javier20ch: ✍️Artículos originales:

May 6, 2023 · 12 shares · 410 followers View post →

Sanjiv J. Shah, MD

@HFpEF · X

@S__Baksh This slide has several key references but the main paper (PARAGON RCT primary results) was published in @NEJM: https://t.co/159mYbUWej https://t.co/eXpCMlJygC

Apr 24, 2023 · 4 likes · 6,012 followers View post →

にいやん

@niiyan51 · X

Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://t.co/QRIoiyoUni

Apr 9, 2023 · 1,074 followers View post →

@theajaydevb · X

Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction | NEJM https://t.co/QYi5RxRUvy PARAGON-HF trial #MedTwitter https://t.co/Sfvjd1kgEq

Mar 13, 2023 · 4 likes · 277 followers View post →

Jesal

@Jesal191 · X

RT @javier20ch: ✍️Artículos originales:

Feb 24, 2023 · 12 shares · 27 followers View post →

Jamesoto

@Jamesoto14 · X

RT @javier20ch: ✍️Artículos originales:

Feb 23, 2023 · 12 shares · 218 followers View post →

Diego Esteban Revelo

@DRdiegorevelo · X

RT @javier20ch: ✍️Artículos originales:

Feb 19, 2023 · 12 shares · 41 followers View post →

Edward Scissorhands

@Druidaeduardo · X

RT @javier20ch: ✍️Artículos originales:

Feb 17, 2023 · 12 shares · 1,122 followers View post →

Santiago Oquendo MD

@rksanti · X

RT @javier20ch: ✍️Artículos originales:

Feb 15, 2023 · 12 shares · 4,106 followers View post →

David rojas

@Davidgaleno23 · X

RT @javier20ch: ✍️Artículos originales:

Feb 14, 2023 · 12 shares · 27 followers View post →

lucero

@lucymatsu · X

RT @javier20ch: ✍️Artículos originales:

Feb 14, 2023 · 12 shares · 153 followers View post →

MercheRC

@rc_merche · X

RT @javier20ch: ✍️Artículos originales:

Feb 14, 2023 · 12 shares · 311 followers View post →

Juan Carlos Obaya

@jcobaya69 · X

RT @javier20ch: ✍️Artículos originales:

Feb 14, 2023 · 12 shares · 857 followers View post →

Dr. FEVI

@javier20ch · X

✍️Artículos originales:

Feb 14, 2023 · 18 likes · 12 shares · 13,423 followers View post →

Dexmedetomidina

@hexolum_fakir · X

RT @JonathanNefro: SACUBITRIL/VALSARTAN en pacientes con insuficiencia cardíaca y fracción de eyección preservada, redujo 50% el empeoramie…

Jan 23, 2023 · 60 shares · 514 followers View post →

手取りすくな

@summerbody321 · X

https://t.co/vXhQ5MXZTS https://t.co/FVM4hYxGRS

Dec 3, 2022 · 81 followers View post →

Maria Fernanda Chamorro Arias

@MariafdaCh_a · X

RT @clinicasac:

Sep 13, 2022 · 3 shares · 79 followers View post →

carolina salvatori

@dracarosalva · X

RT @clinicasac:

Sep 13, 2022 · 3 shares · 129 followers View post →

Consejo de Cardiología Clínica y Terapéutica

@clinicasac · X

Sep 13, 2022 · 9 likes · 3 shares · 8,107 followers View post →

ﾌｶﾌｶオフトン

@gwA1DqrnYUTegXD · X

RT @Method_Focused: 1回目終わりました。本日取り上げた論文はこちらです。再発事象を扱っている研究です。ディスカッションも活発で楽しかったです☺️ #methodジャーナルクラブ https://t.co/I7e3qYJGV2

Jul 6, 2022 · 3 shares · 253 followers View post →

Shunsuke Oyamada

@oyashun1229 · X

Jul 6, 2022 · 3 shares · 776 followers View post →

Sato Shuntaro｜佐藤俊太朗

@Shuntarooo3 · X

Jul 6, 2022 · 3 shares · 12,143 followers View post →

Method-focused Journal Club

@Method_Focused · X

Jul 6, 2022 · 22 likes · 3 shares · 2,289 followers View post →

Claus F2

@dra_ferrer · X

RT @JonathanNefro: SACUBITRIL/VALSARTAN en pacientes con insuficiencia cardíaca y fracción de eyección preservada, redujo 50% el empeoramie…

Apr 21, 2022 · 60 shares · 253 followers View post →

ときヲ

@toki_wo_koe · X

PARAGON-HFのバルサルタン320mgは、国内のバルサルタンだと200mg。ま？ Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction | NEJM https://t.co/Q6a4ttGSjL

Mar 29, 2022 · 1 like · 2,584 followers View post →

Farmacia Hospital Guadalajara

@Farmacia_HUGU · X

Mar 2, 2022 · 3 likes · 974 followers View post →

take03take

@take03take · X

Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction | NEJM N Engl J Med 2019; 381:1609-1620 医学　論文　ARNI　心血管　HFpEF　心不全 https://t.co/CZxInps7s0

Feb 13, 2022 · 6 followers View post →

にいやん

@niiyan51 · X

Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://t.co/QRIoiyoUni

Dec 15, 2021 · 1,074 followers View post →

Emilio Alegre (farm)

@EmilioAlegre1 · X

Por último, sacubitril+valsartán fue estudiado específicamente en estos pacientes (PARAGON-HF), pero no mostró beneficio en mortalidad ni en hospitalizaciones. https://t.co/xaQqYfnIqB

Dec 10, 2021 · 3 likes · 3,087 followers View post →

Conrad Macon

@cjmacon · X

PARAGON-HF (DOI: 10.1056/NEJMoa1908655) ⬇️ composite death from renal failure, ESRD, or decrease in GFR >50% with ARNI than ARB 1.4% vs. 2.7% (But they excluded eGFR <30) https://t.co/Wyl8O9lQWR

Dec 6, 2021 · 4 likes · 388 followers View post →

はぎ

@hagi220 · X

RT @pinacol: 【S22-5】ARNIはアジア人ではあまり成績が良くないため、導入に慎重になった方がいいかもしれない。 https://t.co/3u3MzXOnm1 #jsphcs2021

Nov 13, 2021 · 1 share · 490 followers View post →

pinacol

@pinacol · X

【S22-5】ARNIはアジア人ではあまり成績が良くないため、導入に慎重になった方がいいかもしれない。 https://t.co/3u3MzXOnm1 #jsphcs2021

Nov 13, 2021 · 1 share · 1,616 followers View post →

pinacol

@pinacol · X

【S21-4】ARNIはACE阻害薬やARBと比較して症候性低血圧の頻度が高い。 https://t.co/eNKN1C5R0I https://t.co/3u3MzXOnm1 https://t.co/ZcEhsanorH #jsphcs2021

Nov 13, 2021 · 1 like · 1,616 followers View post →

Dr. med. Levin Kaan B.

@kaan_levin · X

Sonuçları, 3 yıl önce bilinen ve karşılaştırılabilir bir hasta grubunda arni sacubitril/valsartan kullanılan PARAGON çalışmasıyla da kısaca ilişkilendirmek istiyorum. https://t.co/lgEbtMnuW1

Sep 8, 2021 · 11,782 followers View post →

Carlos Palacio

@CAPE1223 · X

RT @jsenior64: https://t.co/ut7rSomSg8 https://t.co/Gy5hIZwDnz

Aug 29, 2021 · 1 share · 1,033 followers View post →

Juan Senior

@jsenior64 · X

https://t.co/ut7rSomSg8 https://t.co/Gy5hIZwDnz

Aug 29, 2021 · 3 likes · 1 share · 11,063 followers View post →

Almudena Castro Conde

@almucastro01 · X

@baro_dr Sacu/val no demostró beneficio en esta población. Estudio PARAGON-HF https://t.co/gdV4AVMBFE

Jul 8, 2021 · 1 like · 16,037 followers View post →

色々自粛中(ガラス細工の様な繊細なハートを持つ貴公子

@ECGEPSCADEVICE · X

RT @KazNegishiMD: ARNIのPARAGON-HFとは対照的 https://t.co/iNX9PxnSHp

Jul 6, 2021 · 2 shares · 9,357 followers View post →

Takuya Kishi @ねこ好き循環器内科医

@tkishi_cardiol · X

RT @KazNegishiMD: ARNIのPARAGON-HFとは対照的 https://t.co/iNX9PxnSHp

Jul 6, 2021 · 2 shares · 14,694 followers View post →

根岸一明MD/PhD/MSc @シドニー

@KazNegishiMD · X

ARNIのPARAGON-HFとは対照的 https://t.co/iNX9PxnSHp

Jul 6, 2021 · 11 likes · 2 shares · 1,520 followers View post →

Maria A. Pabón, MD

@mapabonp · X

RT @CardioNerdsJC: ♥️

May 11, 2021 · 1 share · 1,372 followers View post →

CardioNerds Journal Club

@CardioNerdsJC · X

♥️

May 11, 2021 · 6 likes · 1 share · 8,222 followers View post →

@doctorvec · X

https://t.co/Z9jm1JB9iS

May 7, 2021 · 231 followers View post →

Esther Marco Tejón

@emarcotejon · X

RT @rincondesisifo: (NEJM) Sacubitrilo valsartán no disminuye de forma significativa la tasa de reingresos ni la mortalidad de origen CV en…

Apr 23, 2021 · 20 shares · 314 followers View post →

Yasser UMKCRCT

@ymhs92 · X

PARAGON-HF: The use of ARNI in diastolic heart failure with preserved ejection fraction did not achieve the primary outcome of cardiovascular death or hospitalizations for HF compared with valsartan #UMKCRCT https://t.co/nhlOZfgDvX

Apr 19, 2021 · 10 followers View post →

Dr. Pedro A. Carrillo Moreno

@cardiodocpedro · X

Apr 8, 2021 · 4,251 followers View post →

MedPearls

@MedPearls1 · X

Apr 6, 2021 · 91 followers View post →

ACCP Cardiology PRN

@accpcardprn · X

@ASYAlyounis True! Although not 1 of the selections here, sacubitril-valsartan is now approved for HF patients regardless of EF, and as @iamcrsmith mentioned, PARAGON-HF showed a decrease in the primary outcome (CV death/HF hosp) particularly in subgroup w/ EF</=57%. https://t.co/b9oKiFLHks

Mar 22, 2021 · 2 likes · 9,294 followers View post →

Takuya Kishi @ねこ好き循環器内科医

@tkishi_cardiol · X

RT @CircSM: @muhammedi_ali @beirieeJR 外からすみません、それぞれPARADIGM(rEF)はエナラプリル(ACEi)、PARAGON(pEF)はバルサルタン(ARB)との比較試験になりますm(_ _)m https://t.co/vjT7…

Mar 17, 2021 · 1 share · 14,694 followers View post →

Patrick Myers

@pomyers · X

RT @drjohnm: Interesting happens at #FDA CV AdCom meeting on #entresto indications for HFpEF Good slides from @afshinfarzan https://t.c…

Mar 14, 2021 · 3 shares · 5,455 followers View post →

Juan Senior

@jsenior64 · X

https://t.co/ut7rSomSg8

Feb 17, 2021 · 11,063 followers View post →

رزان الوهيب

@razan_222 · X

RT @87HISHAM: خبر مهم جدا: من اهم التطورات في السنوات الطويلة الماضية في علاج HFpEF بالذات حيث منحت @US_FDA الضوء الاخضر لشركة @NovartisFD…

Feb 17, 2021 · 3 shares · 1,414 followers View post →

Hala Joharji l هلا جوهرجي

@halajoharji · X

Feb 17, 2021 · 3 shares · 1,631 followers View post →

Hisham Badreldin

@87HISHAM · X

Feb 17, 2021 · 9 likes · 3 shares · 10,575 followers View post →

Mitchell Psotka

@mpsotka · X

@kuch_batein @MunirJanmohamed @gcfmd @LiviuKlein @ajaysmd @DrNasrien @RajeevCMohan @jtheywood #PARAGON-HF https://t.co/rVqJ3zxxX7

Feb 12, 2021 · 2,191 followers View post →

Venk Murthy MD PhD

@venkmurthy · X

RT @drjohnm: Interesting happens at #FDA CV AdCom meeting on #entresto indications for HFpEF Good slides from @afshinfarzan https://t.c…

Dec 18, 2020 · 3 shares · 22,342 followers View post →

名前

@akkiii0830 · X

Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://t.co/tSchoH59yb https://t.co/la7JHf1xZH

Dec 16, 2020 · 246 followers View post →

Afshin Farzaneh-Far, MD PhD

@afshinfarzan · X

RT @drjohnm: Interesting happens at #FDA CV AdCom meeting on #entresto indications for HFpEF Good slides from @afshinfarzan https://t.c…

Dec 15, 2020 · 3 shares · 2,450 followers View post →

John Mandrola, MD

@drjohnm · X

Dec 15, 2020 · 12 likes · 3 shares · 68,474 followers View post →

Tobenna Iyidobi

@Tobennaiyidobi · X

RT @hahn_rt: PARAGON suggests no benefit Sacubitril / Valsartan in HFpEF #ESCCongress #ESCcongress2019 https://t.co/ygAtAKMAKy https://t.c…

Sep 7, 2020 · 20 shares · 191 followers View post →

Dr. Martha Gulati ♥️

@DrMarthaGulati · X

RT @EGarciaSayan: @SriHarshagr1 @purviparwani @BurkertPieske @rudolf_deboer @iamritu @mmamas1973 @hvanspall @DrMarthaGulati @ErinMichos Thi…

Aug 30, 2020 · 1 share · 64,755 followers View post →

Enrique Garcia-Sayan, MD, FACC, FASE

@EGarciaSayan · X

@SriHarshagr1 @purviparwani @BurkertPieske @rudolf_deboer @iamritu @mmamas1973 @hvanspall @DrMarthaGulati @ErinMichos This was a quality of life study. PARAGON-HF already answered the question about mortality (no benefit). https://t.co/vluka1WOzm Management of HFpEF remains challenging and there is no "magic drug".

Aug 30, 2020 · 4 likes · 1 share · 3,991 followers View post →

青島周一@【書籍】「生成AIと学ぶ医学論文の読み方・考え方」発売中！

@syuichiao89 · X

サクビトリル・バルサルタン HFrEF https://t.co/RoWmfxqcSN HFpEF https://t.co/nNSVZZLp1N Acute Heart Failure https://t.co/AuxhpB0Glb

Jul 23, 2020 · 1 like · 8,604 followers View post →

Tariq Ahmad MD MPH

@yaleHFdoc · X

RT @hmkyale: This is trial result @NEJM: 'rate ratio, 0.87;95% CI, 0.75 to 1.01; P=0.06).’ This, for people w/heart failure and preserved e…

Jul 20, 2020 · 1 share · 4,622 followers View post →

Harlan Krumholz

@hmkyale · X

This is trial result @NEJM: 'rate ratio, 0.87;95% CI, 0.75 to 1.01; P=0.06).’ This, for people w/heart failure and preserved ejection fraction. Few treatment options. Should we move from thinking of trials as positive or negative? Should use be increasing? https://t.co/vtrLDQBG9Q https://t.co/h3pOm6UUus

Jul 20, 2020 · 8 likes · 1 share · 26,515 followers View post →

☫кептагоп™Я☫

@kentaron1971 · X

https://t.co/MA1ny01pCA

Jun 29, 2020 · 12,424 followers View post →

Mazen Albaghdadi MD MSc

@malbag1 · X

Curious indeed https://t.co/i2vHqAEVZj https://t.co/O95Z0hl7mu

Jun 25, 2020 · 1 like · 434 followers View post →

Ethan J. Weiss

@ethanjweiss · X

@cardiobrief https://t.co/sGMLJTlQoO

Jun 24, 2020 · 30,103 followers View post →

Thuo

@ThuoPap · X

Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction. Reply. https://t.co/OOsVxM4Wr1

Mar 19, 2020 · 1,470 followers View post →

Thuo

@ThuoPap · X

Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction. https://t.co/PfFkm9kWEo

Mar 19, 2020 · 1,470 followers View post →

DeLasSalas

@DrDeLasSalasGER · X

Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction | NEJM https://t.co/Lqe3reGvEV

Jan 11, 2020 · 690 followers View post →

KristopherMaday PA-C

@PA_Maday · X

PARAGON-HF Trial Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://t.co/0J192LFkQw https://t.co/FSsGCu7tZO

Jan 9, 2020 · 2,458 followers View post →

ILozano

@i_lozanomontoya · X

RT @DrMqAgMas: Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction ⁦@NEJM⁩ #PildorasGBE ⁦@semeg_es⁩ https:…

Dec 12, 2019 · 1 share · 775 followers View post →

Cannibal B. Buress

@StnbckTaughtMe · X

Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction | NEJM https://t.co/eyOQBFcowr

Dec 12, 2019 · 1,020 followers View post →

Miquel Mas

@DrMqAgMas · X

Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction ⁦@NEJM⁩ #PildorasGBE ⁦@semeg_es⁩ https://t.co/V47VxytvwQ

Dec 12, 2019 · 1 share · 2,465 followers View post →

mary runde

@rundem · X

RT @AACNme: A study finds that sacubitril–valsartan doesn’t significantly reduce hospitalizations and death from #cardiovascular causes amo…

Nov 26, 2019 · 3 shares · 966 followers View post →

Bibong Telebong

@aljaim1 · X

RT @AACNme: A study finds that sacubitril–valsartan doesn’t significantly reduce hospitalizations and death from #cardiovascular causes amo…

Nov 26, 2019 · 3 shares · 243 followers View post →

Oregon SCCM

@OregonSccm · X

RT @AACNme: A study finds that sacubitril–valsartan doesn’t significantly reduce hospitalizations and death from #cardiovascular causes amo…

Nov 25, 2019 · 3 shares · 84 followers View post →

American Association of Critical-Care Nurses

@AACNme · X

A study finds that sacubitril–valsartan doesn’t significantly reduce hospitalizations and death from #cardiovascular causes among patients who have heart failure with preserved ejection fraction. Read More: https://t.co/NQd4lxEe9P via @NEJM #AACN #CriticalCare #Nursing #Nurse

Nov 25, 2019 · 3 likes · 3 shares · 25,612 followers View post →

pharmaciensAPES

@pharmaciensAPES · X

Résultats étude PARAGON-HF|Utilisation du sacubitril-valsartan vs valsartan pour les patients insuffisants cardiaques avec FEVG préservée ne démontrent pas de bénéfices significatifs sur la diminution des hospitalisations ou la mortalité cardiovasculaire https://t.co/9j5O2zdrcV https://t.co/6chE9H58wt

Nov 25, 2019 · 1 like · 895 followers View post →

ぽん@

@pharma_pon · X

ARNIはバルサルタンより血圧は下がりやすいが腎機能悪化は少なそう。 ARBに対して優越性示せてないけど個人的にはHFｐEFにもある程度効果があるように思うけど・・・ Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction | NEJM https://t.co/HeTckdyDtf

Nov 18, 2019 · 2 likes · 973 followers View post →

ときヲ

@toki_wo_koe · X

#PARAGON-HF #HFpEF にいい薬はないか〜。Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction | NEJM https://t.co/PBAanWwK93

Nov 15, 2019 · 2,584 followers View post →

Fausto_Edmundo

@fausto_edmundo · X

Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction | NEJM. Era de esperarse... https://t.co/t3Rw7dwycK

Nov 14, 2019 · 38 followers View post →

官澤洋平 YK Hospitalist

@Yohei_Kanzawa · X

ESCの時にon line firstでみたやつですね。sacubitrilも #HFpEF では有効性示せず。HFpEFが併存症の管理がメインなのはかわらず、やはり総合医の腕の見せ所。 #sacubitril Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction | NEJM https://t.co/sHt25j4zkH

Nov 12, 2019 · 3,212 followers View post →

Steven Zhang

@Stevenzhangzero · X

RT @trogersresearch: In PARAGON-HF trial, sacubitril–valsartan did not significantly lower rate of total hospitalizations for heart failure…

Nov 11, 2019 · 3 shares · 33 followers View post →

Chile717

@Chile7171 · X

RT @Lguevaramath: Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction | NEJM https://t.co/fgcUAZuNI7

Nov 10, 2019 · 2 shares · 687 followers View post →

ziomara chacon

@ziomarach · X

RT @Lguevaramath: Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction | NEJM https://t.co/fgcUAZuNI7

Nov 10, 2019 · 2 shares · 98 followers View post →

Lempira Guevara Matheus

@Lguevaramath · X

Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction | NEJM https://t.co/fgcUAZuNI7

Nov 10, 2019 · 3 likes · 2 shares · 1,180 followers View post →

Joel M. Topf, MD FACP

@kidney_boy · X

RT @GenNextMD: #KidneyWk Parent trial was a negative one. @NEJM https://t.co/n85E2WYHcV

Nov 8, 2019 · 1 share · 63,281 followers View post →

TEJAS PATEL MD, FACP, FASN

@GenNextMD · X

#KidneyWk Parent trial was a negative one. @NEJM https://t.co/n85E2WYHcV

Nov 8, 2019 · 1 like · 1 share · 1,122 followers View post →

CancerEpiPapers

@CancerEpibot · X

Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction. N Engl J Med #cancer #epidemiology https://t.co/2ZssgLW7SO

Nov 7, 2019 · 139 followers View post →

renalRCTs

@renalRCTs · X

Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction. https://t.co/idHT9hAGNk

Nov 7, 2019 · 39 followers View post →

iris salinas meza

@isalinas14 · X

RT @RevistaMFSamfyc: Inhibición con angiotensina-neprilysina en la insuficiencia cardiaca con fracción de eyección preservada https://t.co/…

Nov 7, 2019 · 2 shares · 31 followers View post →

Val Rac

@DrValRac · X

RT @trogersresearch: In PARAGON-HF trial, sacubitril–valsartan did not significantly lower rate of total hospitalizations for heart failure…

Nov 7, 2019 · 3 shares · 826 followers View post →

Natasha Aleksova

@natashaaleksova · X

RT @trogersresearch: In PARAGON-HF trial, sacubitril–valsartan did not significantly lower rate of total hospitalizations for heart failure…

Nov 7, 2019 · 3 shares · 132 followers View post →

Ted Rogers Centre for Heart Research

@trogersresearch · X

In PARAGON-HF trial, sacubitril–valsartan did not significantly lower rate of total hospitalizations for heart failure or CV death among patients with ejection fraction >45% https://t.co/L6sS8Q6FDK https://t.co/Xp4MUvKPBD

Nov 7, 2019 · 1 like · 3 shares · 2,319 followers View post →

Antonio Manteca

@amango30 · X

RT @RevistaMFSamfyc: Inhibición con angiotensina-neprilysina en la insuficiencia cardiaca con fracción de eyección preservada https://t.co/…

Nov 6, 2019 · 2 shares · 139 followers View post →

Revista MFAndalucia

@RevistaMFSamfyc · X

Inhibición con angiotensina-neprilysina en la insuficiencia cardiaca con fracción de eyección preservada https://t.co/FUU7jZzaR3 PMID 31475794

Nov 6, 2019 · 1 like · 2 shares · 722 followers View post →

Adams CardioMD

@AdamsCardioMD · X

Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction | NEJM https://t.co/9UUthvfxsn

Nov 4, 2019 · 607 followers View post →

Chile717

@Chile7171 · X

RT @NEJM: #VisualAbstract: Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://t.co/cgqETZ0Dvd http…

Nov 2, 2019 · 74 shares · 687 followers View post →

Carmen Marín

@car73x · X

RT @NEJM: #VisualAbstract: Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://t.co/cgqETZ0Dvd http…

Nov 1, 2019 · 74 shares · 502 followers View post →

Euri Rivas

@euri_rivas · X

RT @NEJM: #VisualAbstract: Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://t.co/cgqETZ0Dvd http…

Oct 31, 2019 · 74 shares · 48 followers View post →

Lempira Guevara Matheus

@Lguevaramath · X

RT @NEJM: #VisualAbstract: Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://t.co/cgqETZ0Dvd http…

Oct 30, 2019 · 74 shares · 1,180 followers View post →

Ivan Mendoza

@mencardio · X

RT @NEJM: #VisualAbstract: Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://t.co/cgqETZ0Dvd http…

Oct 30, 2019 · 74 shares · 7,255 followers View post →

carol rovira

@patxcarito · X

RT @rincondesisifo: (NEJM) Sacubitrilo valsartán no mejor que valsartán en pac con ICC y FE conservada https://t.co/tuPwA07NfS ECA #PARAGON…

Oct 30, 2019 · 4 shares · 159 followers View post →

Abhishek Kulkarni

@AbhiKulk82 · X

RT @NEJM: #VisualAbstract: Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://t.co/cgqETZ0Dvd http…

Oct 30, 2019 · 74 shares · 520 followers View post →

Mister PandaDoc

@Jairoaguilar27 · X

RT @NEJM: #VisualAbstract: Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://t.co/cgqETZ0Dvd http…

Oct 30, 2019 · 74 shares · 1,894 followers View post →

Curie-osity

@Annisaragi · X

RT @NEJM: #VisualAbstract: Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://t.co/cgqETZ0Dvd http…

Oct 30, 2019 · 74 shares · 254 followers View post →

Hernandez Edgar

@Internistacl · X

RT @NEJM: #VisualAbstract: Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://t.co/cgqETZ0Dvd http…

Oct 30, 2019 · 74 shares · 519 followers View post →

Enrique Vera León

@enriqueveraMD · X

RT @NEJM: #VisualAbstract: Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://t.co/cgqETZ0Dvd http…

Oct 29, 2019 · 74 shares · 1,442 followers View post →

LuvLi

@LuvianoIleana · X

RT @NEJM: #VisualAbstract: Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://t.co/cgqETZ0Dvd http…

Oct 29, 2019 · 74 shares · 49 followers View post →

M Ahmed

@marehan777 · X

RT @NEJM: #VisualAbstract: Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://t.co/cgqETZ0Dvd http…

Oct 29, 2019 · 74 shares · 464 followers View post →

John P Erwin III MD MBA MACC (#BigPoppy )

@HeartOTXHeartMD · X

RT @NEJM: #VisualAbstract: Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://t.co/cgqETZ0Dvd http…

Oct 29, 2019 · 74 shares · 39,661 followers View post →

hataboSAN

@hataboSAN · X

RT @NEJM: #VisualAbstract: Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://t.co/cgqETZ0Dvd http…

Oct 29, 2019 · 74 shares · 997 followers View post →

محذوف

@milardport · X

RT @NEJM: #VisualAbstract: Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://t.co/cgqETZ0Dvd http…

Oct 29, 2019 · 74 shares · 298 followers View post →

Federación Médica Colombiana FMC

@FedemedicaC · X

RT @NEJM: #VisualAbstract: Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://t.co/cgqETZ0Dvd http…

Oct 29, 2019 · 74 shares · 23,901 followers View post →

猫になりたい薬剤師

@Vannyamoto · X

RT @NEJM: #VisualAbstract: Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://t.co/cgqETZ0Dvd http…

Oct 29, 2019 · 74 shares · 1,043 followers View post →

Miquel

@drago54Miquel · X

RT @NEJM: #VisualAbstract: Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://t.co/cgqETZ0Dvd http…

Oct 29, 2019 · 74 shares · 220 followers View post →

Sunit-Preet Chaudhry

@SunitChaudhryMD · X

RT @NEJM: #VisualAbstract: Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://t.co/cgqETZ0Dvd http…

Oct 29, 2019 · 74 shares · 1,038 followers View post →

markbam

@bammarklee · X

RT @NEJM: #VisualAbstract: Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://t.co/cgqETZ0Dvd http…

Oct 29, 2019 · 74 shares · 108 followers View post →

Chile717

@Chile7171 · X

RT @NEJM: #VisualAbstract: Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://t.co/cgqETZ0Dvd http…

Oct 29, 2019 · 74 shares · 687 followers View post →

International University of the Health Sciences

@IUHSmedicine · X

RT @NEJM: #VisualAbstract: Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://t.co/cgqETZ0Dvd http…

Oct 29, 2019 · 74 shares · 57 followers View post →

T. A. Marnegie

@TAMarnegie · X

RT @NEJM: #VisualAbstract: Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://t.co/cgqETZ0Dvd http…

Oct 29, 2019 · 74 shares · 139 followers View post →

Mahmoud Abdellatif

@Mah_abdellatif · X

RT @NEJM: #VisualAbstract: Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://t.co/cgqETZ0Dvd http…

Oct 29, 2019 · 74 shares · 625 followers View post →

Andrés Salazar

@AndresAccount · X

RT @NEJM: #VisualAbstract: Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://t.co/cgqETZ0Dvd http…

Oct 29, 2019 · 74 shares · 880 followers View post →

Abdullah Haitham AlOmar

@AbdullahhAlOmar · X

RT @NEJM: #VisualAbstract: Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://t.co/cgqETZ0Dvd http…

Oct 29, 2019 · 74 shares · 734 followers View post →

Iván

@Dockat16 · X

RT @NEJM: #VisualAbstract: Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://t.co/cgqETZ0Dvd http…

Oct 29, 2019 · 74 shares · 86 followers View post →

irene rilo

@irilomiranda · X

RT @NEJM: #VisualAbstract: Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://t.co/cgqETZ0Dvd http…

Oct 29, 2019 · 74 shares · 513 followers View post →

Carlos Alberto Denis

@Dsolaris88 · X

RT @NEJM: #VisualAbstract: Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://t.co/cgqETZ0Dvd http…

Oct 29, 2019 · 74 shares · 200 followers View post →

pedro gutierrez j

@alameda98 · X

RT @NEJM: #VisualAbstract: Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://t.co/cgqETZ0Dvd http…

Oct 29, 2019 · 74 shares · 541 followers View post →

Darth Kiki

@enriquegnzz · X

RT @NEJM: #VisualAbstract: Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://t.co/cgqETZ0Dvd http…

Oct 29, 2019 · 74 shares · 470 followers View post →

Abdulrazaq Al-Jazairi

@AbdulrazaqAlJa3 · X

RT @NEJM: #VisualAbstract: Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://t.co/cgqETZ0Dvd http…

Oct 29, 2019 · 74 shares · 4,098 followers View post →

El_Nefro

@NefrologoCancun · X

RT @NEJM: #VisualAbstract: Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://t.co/cgqETZ0Dvd http…

Oct 29, 2019 · 74 shares · 274 followers View post →

บันดาลลงบันไดบันทึกให้จำจงดี

@BUNBYA · X

RT @NEJM: #VisualAbstract: Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://t.co/cgqETZ0Dvd http…

Oct 29, 2019 · 74 shares · 54 followers View post →

Luca Kat

@_Luca_Catapano · X

RT @NEJM: #VisualAbstract: Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://t.co/cgqETZ0Dvd http…

Oct 29, 2019 · 74 shares · 45 followers View post →

Ｓｌｉｐｓｔｒｅａｍ

@ChapKrodit · X

RT @NEJM: #VisualAbstract: Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://t.co/cgqETZ0Dvd http…

Oct 29, 2019 · 74 shares · 71 followers View post →

Mohammed Bahatheg

@M_Bahatheg · X

RT @NEJM: #VisualAbstract: Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://t.co/cgqETZ0Dvd http…

Oct 29, 2019 · 74 shares · 3,356 followers View post →

RIM

@Ricardoscientia · X

RT @NEJM: #VisualAbstract: Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://t.co/cgqETZ0Dvd http…

Oct 29, 2019 · 74 shares · 915 followers View post →

د/محمد بن حسن العبود، Dr.Mohammad Alaboud

@MoAlaboud · X

RT @NEJM: #VisualAbstract: Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://t.co/cgqETZ0Dvd http…

Oct 29, 2019 · 74 shares · 163 followers View post →

Regularly Irregular

@Zain_Bloch · X

RT @NEJM: #VisualAbstract: Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://t.co/cgqETZ0Dvd http…

Oct 29, 2019 · 74 shares · 451 followers View post →

RODRIGO LUNA

@RODRIGO32984659 · X

RT @NEJM: #VisualAbstract: Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://t.co/cgqETZ0Dvd http…

Oct 29, 2019 · 74 shares · 19 followers View post →

Felipe Sebastián

@PipeTatanVP · X

RT @NEJM: #VisualAbstract: Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://t.co/cgqETZ0Dvd http…

Oct 29, 2019 · 74 shares · 1,167 followers View post →

Tony Merheb

@TonyMer3eb · X

RT @NEJM: #VisualAbstract: Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://t.co/cgqETZ0Dvd http…

Oct 29, 2019 · 74 shares · 240 followers View post →

Kike Arenas_

@arenas_hoyos · X

RT @NEJM: #VisualAbstract: Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://t.co/cgqETZ0Dvd http…

Oct 29, 2019 · 74 shares · 109 followers View post →

VAN NGUYEN, MD, FACC

@HAVIMD · X

RT @NEJM: #VisualAbstract: Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://t.co/cgqETZ0Dvd http…

Oct 29, 2019 · 74 shares · 794 followers View post →

Hasoma

@BtosEfra · X

RT @NEJM: #VisualAbstract: Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://t.co/cgqETZ0Dvd http…

Oct 29, 2019 · 74 shares · 74 followers View post →

Iván Arroyo Fernánde

@ArroyoFernande · X

RT @NEJM: #VisualAbstract: Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://t.co/cgqETZ0Dvd http…

Oct 29, 2019 · 74 shares · 3,083 followers View post →

Hanna Gaggin

@HannaGaggin · X

RT @NEJM: #VisualAbstract: Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://t.co/cgqETZ0Dvd http…

Oct 29, 2019 · 74 shares · 1,613 followers View post →

Jessica

@JJT040797 · X

RT @NEJM: #VisualAbstract: Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://t.co/cgqETZ0Dvd http…

Oct 29, 2019 · 74 shares · 303 followers View post →

Hussein Nasib, M.D,MBA-CM

@nasib_dexie · X

RT @NEJM: #VisualAbstract: Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://t.co/cgqETZ0Dvd http…

Oct 29, 2019 · 74 shares · 460 followers View post →

Diego Gaete Forno

@dgforno · X

RT @NEJM: #VisualAbstract: Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://t.co/cgqETZ0Dvd http…

Oct 29, 2019 · 74 shares · 2,065 followers View post →

María Isabel Rodríguez

@rodriguezc_mary · X

RT @NEJM: #VisualAbstract: Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://t.co/cgqETZ0Dvd http…

Oct 29, 2019 · 74 shares · 81 followers View post →

Pedro Valdes DO FACC

@VTpete412 · X

RT @NEJM: #VisualAbstract: Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://t.co/cgqETZ0Dvd http…

Oct 29, 2019 · 74 shares · 141 followers View post →

aquautumica

@nriautumnz · X

RT @NEJM: #VisualAbstract: Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://t.co/cgqETZ0Dvd http…

Oct 29, 2019 · 74 shares · 227 followers View post →

R.Ricaño

@rricanorocha · X

RT @NEJM: #VisualAbstract: Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://t.co/cgqETZ0Dvd http…

Oct 29, 2019 · 74 shares · 484 followers View post →

Zahraa Habeeb

@zahraahabeeb · X

RT @NEJM: #VisualAbstract: Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://t.co/cgqETZ0Dvd http…

Oct 29, 2019 · 74 shares · 265 followers View post →

Nieves Tarin Vicente

@nieves_tarin · X

RT @NEJM: #VisualAbstract: Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://t.co/cgqETZ0Dvd http…

Oct 29, 2019 · 74 shares · 743 followers View post →

Pub Health Monitor

@monitor_PH · X

RT @NEJM: #VisualAbstract: Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://t.co/cgqETZ0Dvd http…

Oct 29, 2019 · 74 shares · 1,825 followers View post →

NEJM

@NEJM · X

#VisualAbstract: Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://t.co/cgqETZ0Dvd https://t.co/itQPIQrfQA

Oct 29, 2019 · 142 likes · 74 shares · 935,699 followers View post →

Rto1

@guncannnn · X

RT @NEJM: Original Article: Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://t.co/5oOkYhrROV

Oct 27, 2019 · 36 shares · 717 followers View post →

Masanobu Miu

@MiuMsnb · X

RT @NEJM: Original Article: Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://t.co/5oOkYhrROV

Oct 27, 2019 · 36 shares · 420 followers View post →

Shaylika Chauhan MD, FACP

@drshaylika · X

RT @NEJM: Original Article: Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://t.co/5oOkYhrROV

Oct 27, 2019 · 36 shares · 115 followers View post →

Elvis Amao Ruiz

@elvisjar · X

RT @NEJM: Original Article: Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://t.co/5oOkYhrROV

Oct 27, 2019 · 36 shares · 253 followers View post →

Lancellotti

@cardiopole · X

RT @NEJM: Original Article: Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://t.co/5oOkYhrROV

Oct 27, 2019 · 36 shares · 1,617 followers View post →

mamylona

@mamylona1 · X

RT @NEJM: Original Article: Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://t.co/5oOkYhrROV

Oct 27, 2019 · 36 shares · 61 followers View post →

Saurabh Singh Rathore

@SSR_Saurabh · X

RT @NEJM: Original Article: Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://t.co/5oOkYhrROV

Oct 27, 2019 · 36 shares · 605 followers View post →

Ivan

@jirdems · X

RT @NEJM: Original Article: Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://t.co/5oOkYhrROV

Oct 26, 2019 · 36 shares · 300 followers View post →

Cardiac Research FDN

@CardiacUK · X

Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction | NEJM https://t.co/rFBhQWZYdn

Oct 26, 2019 · 203 followers View post →

Mitchel Longo

@MitchelRosas · X

RT @NEJM: Original Article: Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://t.co/5oOkYhrROV

Oct 26, 2019 · 36 shares · 1,509 followers View post →

Atif Irshad

@brilliantguy29 · X

RT @NEJM: Original Article: Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://t.co/5oOkYhrROV

Oct 26, 2019 · 36 shares · 36 followers View post →

Chile717

@Chile7171 · X

RT @NEJM: Original Article: Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://t.co/5oOkYhrROV

Oct 26, 2019 · 36 shares · 687 followers View post →

Mana

@manasigh · X

RT @NEJM: Original Article: Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://t.co/5oOkYhrROV

Oct 26, 2019 · 36 shares · 331 followers View post →

Estef!

@estefaniacr132 · X

RT @NEJM: Original Article: Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://t.co/5oOkYhrROV

Oct 26, 2019 · 36 shares · 109 followers View post →

СГАМ

@CGAM2016 · X

RT @NEJM: Original Article: Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://t.co/5oOkYhrROV

Oct 26, 2019 · 36 shares · 235 followers View post →

epocrates

@epocrates · X

Is angiotensin-neprilysin inhibition beneficial in HFpEF? Via @NEJM https://t.co/D0sDwIDuKp

Sep 27, 2019 · 7,442 followers View post →

Kuwait Internists

@Q8Internists · X

Sacubitril–valsartan did not result in a significantly lower rate of total hospitalizations for heart failure and death from cardiovascular causes among patients with heart failure and an ejection fraction of 45% or higher. No proven benefit for HFpEF ! https://t.co/ncniDysFOI

Sep 22, 2019 · 1 like · 1 share · 98 followers View post →

Emmanuel

@eakintoyeMD · X

A 5% absolute risk reduction in a disease with no established tx is not completely negative. P value does not always tell the full story! My only concern with the study was why valsartan was used as control instead of usual care #ACCFIT #beyondPvalue https://t.co/rj4IK1wDOs

Sep 1, 2019 · 1,016 followers View post →

Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction.

Mentions per month

Where it's discussed

What people are saying

Abstract in brief

Top posts

All mentions

Comparative Analysis of Tirzepatide and Semaglutide in Obesity Management

Early Anticoagulation Benefits in Atrial Fibrillation Stroke Patients

Impact of Angiotensin Inhibition on Heart Failure Outcomes

COVID-19 Impact on Cardiology and Heart Failure Management